Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOS1 | P29475 | 14/20 | 1.00 |
| ▸ | NOS3 | P29474 | 11/20 | 1.00 |
| ▸ | NOS2 | P35228 | 4/20 | 0.70 |
| ▸ | HTR3E | A5X5Y0 | 2/20 | 0.67 |
| ▸ | HTR3B | O95264 | 2/20 | 0.67 |
| ▸ | HTR3A | P46098 | 2/20 | 0.67 |
| ▸ | HTR3D | Q70Z44 | 2/20 | 0.67 |
| ▸ | HTR3C | Q8WXA8 | 2/20 | 0.67 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.67 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.67 |
| ▸ | SLC22A3 | O75751 | 1/20 | 0.67 |
| ▸ | PLAU | P00749 | 1/20 | 0.67 |
| ▸ | MEN1 | O00255 | 1/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.58 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.56 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.56 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.56 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.56 |
| ▸ | BLM | P54132 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7448212 | 1.00 | NOS1 (1.00) | NOS1NOS3NOS2HTR3EHTR3B | |
| SCHEMBL6273560 | 1.00 | NOS1 (1.00) | NOS1NOS3NOS2HTR3EHTR3B | |
| SCHEMBL165970 | 0.80 | NOS1 (0.67) | NOS1NOS3NOS2HTR3EHTR3B | |
| SCHEMBL2348627 | 0.80 | NOS1 (0.67) | NOS1NOS3NOS2HTR3EHTR3B | |
| SCHEMBL486925 | 0.80 | NOS1 (0.67) | NOS1NOS3NOS2HTR3EHTR3B | |
| Phenylguanidine SCHEMBL467577 | 0.80 | SLC22A2 (1.00) | NOS1NOS3HTR3EHTR3BHTR3A | |
| SCHEMBL165971 | 0.80 | NOS1 (0.67) | NOS1NOS3NOS2HTR3EHTR3B | |
| SCHEMBL28267587 | 0.79 | NOS1 (0.64) | NOS1NOS3NOS2HTR3EHTR3B | |
| Phenylguanidine SCHEMBL4739913 | 0.78 | SLC22A2 (0.94) | NOS1NOS3HTR3EHTR3BHTR3A | |
| SCHEMBL6650679 | 0.78 | NOS1 (0.64) | NOS1NOS3NOS2HTR3EHTR3B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024027722-A1 | AUXILIARY MASTERBATCH AND USE THEREOF | 天津利安隆新材料股份有限公司 | 2024-02-08 | — | — | WO | claimed |
| CN-117402122-A | Preparation method of sulfentrazone and triazolone-oxadiazon triazolinone intermediate | 宁夏格瑞精细化工有限公司 | 2024-01-16 | — | — | CN | disclosed |
| CN-110627730-A | Novel method for efficiently synthesizing 4-alkenyl quinazoline by C-H activation/cyclization reaction catalyzed by transition metal | 四川大学 | 2019-12-31 | — | — | CN | disclosed |
| CN-102617487-B | Multi-substituted pyrimidinones compounds as well as preparation method and application thereof | UNIV BEIJING TECHNOLOGY | 2014-04-02 | — | — | CN | disclosed |
| CN-102617487-A | Multi-substituted pyrimidinones compounds as well as preparation method and application thereof | UNIV BEIJING TECHNOLOGY | 2012-08-01 | — | — | CN | disclosed |
| JP-2010248142-A | 2-BENZYL-4-(4-ALKYLPHENYL)IMIDAZOLE COMPOUND | SHIKOKU CHEM CORP | 2010-11-04 | — | — | JP | disclosed |
| WO-2005115973-A1 | BENZYLFORMAMIDINE COMPOUNDS AND PLASTIC PRODUCTS CONTAINING THE BENZYLFORMAMIDINE COMPOUNDS AS ULTRAVIOLET LIGHT ABSORBERS | ZIKO LTD. (KR) | 2005-12-08 | — | — | WO | disclosed |
| EP-0551330-A4 | SUBSTITUTED AMIDINES HAVING HIGH BINDING TO THE SIGMA RECEPTOR AND THE USE THEREOF | OREGON STATE (US) | 1994-07-06 | — | — | EP | disclosed |
| EP-0551330-A1 | SUBSTITUTED AMIDINES HAVING HIGH BINDING TO THE SIGMA RECEPTOR AND THE USE THEREOF | The STATE OF OREGON acting by and through the STATE BOARD OF HIGHER EDUCATION on behalf of the UNIV. OF OREGON (US) | 1993-07-21 | — | — | EP | disclosed |
| WO-1992004054-A1 | SUBSTITUTED AMIDINES HAVING HIGH BINDING TO THE SIGMA RECEPTOR AND THE USE THEREOF | STATE OF OREGON, acting by and through THE OREGON STATE BOARD OF HIGHER EDUCATION, acting for and on behalf of THE OREGON HEALTH SCIENCES UNIVERSITY, PORTLAND, OREGON, and THE UNIVERSITY OF OREGON, EUGENE, OREGON, Johnson Hall, University of Oregon (US) | 1992-03-19 | — | — | WO | disclosed |